678PDOutcomes based on plasma biomarkers for the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC)
Rimassa, L, Kelley, R K, Meyer, T, Ryoo, B-Y, Merle, P, Park, J-W, Blanc, J-F, Lim, H Y, Tran, A, Borgman-Hagey, A E, Clary, D O, Wang, E, Cheng, A-L, El-Khoueiry, A B, Abou-Alfa, G KVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.006
Date:
October, 2019
File:
PDF, 87 KB
english, 2019
File converter
More search results
More benefits 
